The headline numbers for Integer (ITGR) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street ...

Medical technology company Integer Holdings (NYSE:ITGR) reported Q1 CY2026 results , but sales were flat year on year at $439 ...

Shares of Integer (NYSE: ITGR), a company specializing in the development and manufacturing of medical devices, saw a substantial decline of 32% on October 23, 2025. This notable drop was mainly due ...

Integer Holdings cut its 2026 sales and earnings forecasts due to reduced customer orders in its electrophysiology segment and broader risk adjustments, while stressing the changes are temporary.

This disposition represented 15.85% of Thomas' direct common stockholdings at the time of the transaction. The transaction was executed via direct ownership; no indirect entities or derivative ...

CEO Payman Khales reported that "sales and adjusted EPS towards the high end of the outlook range we provided in October." He stated for the full year, "sales increased 8% on a reported basis and over ...

Earnings call Integer Holdings reported Q3 2025 revenue of $468M (+8% YoY), adjusted EPS of $1.79 (+25% YoY), and adjusted operating income up 14%. Despite strong execution, the company reduced its ...

Integer (ITGR) came out with quarterly earnings of $1.79 per share, beating the Zacks Consensus Estimate of $1.68 per share. This compares to earnings of $1.43 per share a year ago. These figures are ...

Business: Integer Holdings Corporation is a medical device contract development and manufacturing company. Its brands include Greatbatch Medical and Lake Region Medical. The company's Cardio & ...